342 related articles for article (PubMed ID: 29795476)
1. A recurrent de novo CUX2 missense variant associated with intellectual disability, seizures, and autism spectrum disorder.
Barington M; Risom L; Ek J; Uldall P; Ostergaard E
Eur J Hum Genet; 2018 Sep; 26(9):1388-1391. PubMed ID: 29795476
[TBL] [Abstract][Full Text] [Related]
2. The epilepsy phenotypic spectrum associated with a recurrent CUX2 variant.
Chatron N; Møller RS; Champaigne NL; Schneider AL; Kuechler A; Labalme A; Simonet T; Baggett L; Bardel C; Kamsteeg EJ; Pfundt R; Romano C; Aronsson J; Alberti A; Vinci M; Miranda MJ; Lacroix A; Marjanovic D; des Portes V; Edery P; Wieczorek D; Gardella E; Scheffer IE; Mefford H; Sanlaville D; Carvill GL; Lesca G
Ann Neurol; 2018 May; 83(5):926-934. PubMed ID: 29630738
[TBL] [Abstract][Full Text] [Related]
3. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
[TBL] [Abstract][Full Text] [Related]
4. Trio exome sequencing identified a novel de novo WASF1 missense variant leading to recurrent site substitution in a Chinese patient with developmental delay, microcephaly, and early-onset seizures: A mutational hotspot p.Trp161 and literature review.
Zhao A; Zhou R; Gu Q; Liu M; Zhang B; Huang J; Yang B; Yao R; Wang J; Lv H; Wang J; Shen Y; Wang H; Chen X
Clin Chim Acta; 2021 Dec; 523():10-18. PubMed ID: 34478686
[TBL] [Abstract][Full Text] [Related]
5. Constraint and conservation of paired-type homeodomains predicts the clinical outcome of missense variants of uncertain significance.
Thai MHN; Gardner A; Redpath L; Mattiske T; Dearsley O; Shaw M; Vulto-van Silfhout AT; Pfundt R; Dixon J; McGaughran J; Pérez-Jurado LA; Gécz J; Shoubridge C
Hum Mutat; 2020 Aug; 41(8):1407-1424. PubMed ID: 32383243
[TBL] [Abstract][Full Text] [Related]
6. Further evidence of a causal association between AGO1, a critical regulator of microRNA formation, and intellectual disability/autism spectrum disorder.
Sakaguchi A; Yamashita Y; Ishii T; Uehara T; Kosaki K; Takahashi T; Takenouchi T
Eur J Med Genet; 2019 Jun; 62(6):103537. PubMed ID: 30213762
[TBL] [Abstract][Full Text] [Related]
7. A ZFHX4 mutation associated with a recognizable neuropsychological and facial phenotype.
Fontana P; Ginevrino M; Bejo K; Cantalupo G; Ciavarella M; Lombardi C; Maioli M; Scarano F; Costabile C; Novelli A; Lonardo F
Eur J Med Genet; 2021 Nov; 64(11):104321. PubMed ID: 34461323
[TBL] [Abstract][Full Text] [Related]
8. De novo missense variants in the E3 ubiquitin ligase adaptor KLHL20 cause a developmental disorder with intellectual disability, epilepsy, and autism spectrum disorder.
Sleyp Y; Valenzuela I; Accogli A; Ballon K; Ben-Zeev B; Berkovic SF; Broly M; Callaerts P; Caylor RC; Charles P; Chatron N; Cohen L; Coppola A; Cordeiro D; Cuccurullo C; Cuscó I; Janette diMonda ; Duran-Romaña R; Ekhilevitch N; Fernández-Alvarez P; Gordon CT; Isidor B; Keren B; Lesca G; Maljaars J; Mercimek-Andrews S; Morrow MM; Muir AM; ; Rousseau F; Salpietro V; Scheffer IE; Schnur RE; Schymkowitz J; Souche E; Steyaert J; Stolerman ES; Vengoechea J; Ville D; Washington C; Weiss K; Zaid R; Sadleir LG; Mefford HC; Peeters H
Genet Med; 2022 Dec; 24(12):2464-2474. PubMed ID: 36214804
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic and genetic spectrum of epilepsy with myoclonic atonic seizures.
Tang S; Addis L; Smith A; Topp SD; Pendziwiat M; Mei D; Parker A; Agrawal S; Hughes E; Lascelles K; Williams RE; Fallon P; Robinson R; Cross HJ; Hedderly T; Eltze C; Kerr T; Desurkar A; Hussain N; Kinali M; Bagnasco I; Vassallo G; Whitehouse W; Goyal S; Absoud M; ; Møller RS; Helbig I; Weber YG; Marini C; Guerrini R; Simpson MA; Pal DK
Epilepsia; 2020 May; 61(5):995-1007. PubMed ID: 32469098
[TBL] [Abstract][Full Text] [Related]
10. Jumonji domain containing 1C (JMJD1C) sequence variants in seven patients with autism spectrum disorder, intellectual disability and seizures.
Slavotinek A; van Hagen JM; Kalsner L; Pai S; Davis-Keppen L; Ohden L; Weber YG; Macke EL; Klee EW; Morava E; Gunderson L; Person R; Liu S; Weiss M
Eur J Med Genet; 2020 Apr; 63(4):103850. PubMed ID: 31954878
[TBL] [Abstract][Full Text] [Related]
11. ASH1L mutation caused seizures and intellectual disability in twin sisters.
Liu H; Liu DT; Lan S; Yang Y; Huang J; Huang J; Fang L
J Clin Neurosci; 2021 Sep; 91():69-74. PubMed ID: 34373061
[TBL] [Abstract][Full Text] [Related]
12. De novo variants in KLF7 are a potential novel cause of developmental delay/intellectual disability, neuromuscular and psychiatric symptoms.
Powis Z; Petrik I; Cohen JS; Escolar D; Burton J; van Ravenswaaij-Arts CMA; Sival DA; Stegmann APA; Kleefstra T; Pfundt R; Chikarmane R; Begtrup A; Huether R; Tang S; Shinde DN
Clin Genet; 2018 May; 93(5):1030-1038. PubMed ID: 29251763
[TBL] [Abstract][Full Text] [Related]
13. De novo missense variants in PPP2R5D are associated with intellectual disability, macrocephaly, hypotonia, and autism.
Shang L; Henderson LB; Cho MT; Petrey DS; Fong CT; Haude KM; Shur N; Lundberg J; Hauser N; Carmichael J; Innis J; Schuette J; Wu YW; Asaikar S; Pearson M; Folk L; Retterer K; Monaghan KG; Chung WK
Neurogenetics; 2016 Jan; 17(1):43-9. PubMed ID: 26576547
[TBL] [Abstract][Full Text] [Related]
14. De novo variants in SP9 cause a novel form of interneuronopathy characterized by intellectual disability, autism spectrum disorder, and epilepsy with variable expressivity.
Tessarech M; Friocourt G; Marguet F; Lecointre M; Le Mao M; Díaz RM; Mignot C; Keren B; Héron B; De Bie C; Van Gassen K; Loisel D; Delorme B; Syrbe S; Klabunde-Cherwon A; Jamra RA; Wegler M; Callewaert B; Dheedene A; Zidane-Marinnes M; Guichet A; Bris C; Van Bogaert P; Biquard F; Lenaers G; Marcorelles P; Ferec C; Gonzalez B; Procaccio V; Vitobello A; Bonneau D; Laquerriere A; Khiati S; Colin E
Genet Med; 2024 May; 26(5):101087. PubMed ID: 38288683
[TBL] [Abstract][Full Text] [Related]
15. De novo variants in CACNA1E found in patients with intellectual disability, developmental regression and social cognition deficit but no seizures.
Royer-Bertrand B; Jequier Gygax M; Cisarova K; Rosenfeld JA; Bassetti JA; Moldovan O; O'Heir E; Burrage LC; Allen J; Emrick LT; Eastman E; Kumps C; Abbas S; Van Winckel G; ; Chabane N; Zackai EH; Lebon S; Keena B; Bhoj EJ; Umair M; Li D; Donald KA; Superti-Furga A
Mol Autism; 2021 Oct; 12(1):69. PubMed ID: 34702355
[TBL] [Abstract][Full Text] [Related]
16. Expanding the genotype-phenotype correlation of de novo heterozygous missense variants in YWHAG as a cause of developmental and epileptic encephalopathy.
Kanani F; Titheradge H; Cooper N; Elmslie F; Lees MM; Juusola J; Pisani L; McKenna C; Mignot C; Valence S; Keren B; Lachlan K; ; Balasubramanian M
Am J Med Genet A; 2020 Apr; 182(4):713-720. PubMed ID: 31926053
[TBL] [Abstract][Full Text] [Related]
17. A de novo mutation in PRICKLE1 associated with myoclonic epilepsy and autism spectrum disorder.
Todd BP; Bassuk AG
J Neurogenet; 2018 Dec; 32(4):313-315. PubMed ID: 29790814
[TBL] [Abstract][Full Text] [Related]
18. Splice variant in ARX leading to loss of C-terminal region in a boy with intellectual disability and infantile onset developmental and epileptic encephalopathy.
Shoubridge C; Jackson M; Grinton B; Berkovic SF; Scheffer IE; Huskins S; Thomas A; Ware T
Am J Med Genet A; 2019 Aug; 179(8):1483-1490. PubMed ID: 31145546
[TBL] [Abstract][Full Text] [Related]
19. Sequencing of sporadic Attention-Deficit Hyperactivity Disorder (ADHD) identifies novel and potentially pathogenic de novo variants and excludes overlap with genes associated with autism spectrum disorder.
Kim DS; Burt AA; Ranchalis JE; Wilmot B; Smith JD; Patterson KE; Coe BP; Li YK; Bamshad MJ; Nikolas M; Eichler EE; Swanson JM; Nigg JT; Nickerson DA; Jarvik GP;
Am J Med Genet B Neuropsychiatr Genet; 2017 Jun; 174(4):381-389. PubMed ID: 28332277
[TBL] [Abstract][Full Text] [Related]
20. Further characterisation of
Gras M; Heide S; Keren B; Valence S; Garel C; Whalen S; Jansen AC; Keymolen K; Stouffs K; Jennesson M; Poirsier C; Lesca G; Depienne C; Nava C; Rastetter A; Curie A; Cuisset L; Des Portes V; Milh M; Charles P; Mignot C; Héron D
J Med Genet; 2024 Jan; 61(2):103-108. PubMed ID: 37879892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
